Abstract
This chapter describes the metabolic parameters of vitamin D and its metabolites according to the framework of pharmacokinetics. The pharmacokinetics of vitamin D is considerably more complex than a standard pharmacological agent, because of the required stepwise hydroxylation into the active form, 1,25(OH)2D, its endogenous, cutaneous synthesis, and presence of vitamin D and its metabolites in the circulation and tissues. Also, its binding to the vitamin D–binding protein (DBP) influences the properties of the vitamin D metabolites. These aspects are discussed throughout this chapter. The absorption, distribution, dose-response, metabolism, excretion, and toxicity of vitamin D and its metabolites are reviewed. In addition, we present the current knowledge of factors influencing 25-hydroxyvitamin D half-life, the influence of DBP on vitamin D metabolism, and the differences in pharmacokinetics between bound and free 25-hydroxyvitamin D.
| Original language | English |
|---|---|
| Title of host publication | Feldman and Pike's Vitamin D |
| Subtitle of host publication | Volume One: Biochemistry, Physiology and Diagnostics |
| Editors | Martin Hewison, Roger Bouillon, JoEllen Welsh |
| Publisher | Elsevier |
| Chapter | 31 |
| Pages | 633-668 |
| Number of pages | 36 |
| Edition | 5 |
| ISBN (Print) | 9780323913867 |
| DOIs | |
| Publication status | Published - 2024 |
Keywords
- Catabolism and excretion
- Dose-response
- Free 25(OH)D
- Metabolism
- Plasma and tissue half-life
- Tissue distribution
- Toxicity
- Vitamin D absorption
- Vitamin D binding protein
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver